US Broker Ratings

Biogen Inc. (BIIB) Stock Analysis: Leveraging a 13% Potential Upside in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, offers significant opportunities for investors with its focus on developing therapies for neurological and neurodegenerative..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Strong Buy with 13% Upside Potential in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers promising investment opportunities as per..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 32% Potential Upside Amid Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a compelling player in the biotechnology sector, focusing on central nervous system (CNS) disorders. With a market capitalization of $6.74..

Tenet Healthcare Corporation (THC) Investor Outlook: Analyzing the 11.55% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a key player in the healthcare sector, is drawing attention from investors with a notable 11.55% potential upside, according to recent..

Humana Inc. (HUM) Stock Report: Evaluating Growth Potential with a 6.18% Upside

Humana Inc. (NYSE: HUM) stands as a formidable player in the healthcare sector, focusing on health insurance plans. With a market cap of $33.46 billion, this..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 15.75% Potential Upside for Investors

Henry Schein, Inc. (NASDAQ: HSIC) remains a formidable player in the healthcare sector, focusing on medical distribution. With its headquarters in Melville, New York, the company..

Zoetis Inc. (ZTS) Stock Analysis: Strong Buy Ratings Signal 30% Upside Potential for Investors

Zoetis Inc. (NYSE: ZTS), a heavyweight in the animal health sector, stands out with a substantial market capitalization of $63.86 billion. As a leading provider of..

Avantor, Inc. (AVTR) Stock Analysis: Unveiling a 16.75% Potential Upside Amidst Market Challenges

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors seeking exposure to..

Encompass Health Corporation (EHC) Stock Analysis: 23% Upside Potential and a Strong Buy Consensus

Encompass Health Corporation (NYSE: EHC) stands as a formidable player within the healthcare sector, specializing in post-acute healthcare services. Based in Birmingham, Alabama, the company operates..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook Highlights 22% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) continues to capture the attention of investors with a promising outlook in the healthcare sector, particularly within the niche of drug..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Uncovering a 30% Potential Upside Amidst Impressive Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a biopharmaceutical company with a focus on genetic diseases and cancers, is making waves in the healthcare sector. With a market..

GSK plc (GSK) Stock Analysis: Navigating Through a Complex Healthcare Landscape

GSK plc (GSK), a stalwart in the healthcare sector, commands a formidable presence in the global drug manufacturing industry. With a robust market capitalization of $94.51..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth with Strategic Collaborations

For investors with an eye on the healthcare sector, Charles River Laboratories International, Inc. (NYSE: CRL) presents a compelling opportunity. With a market cap of $8.86..

Quest Diagnostics (DGX) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Quest Diagnostics Incorporated (NYSE: DGX) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a commanding market cap..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and Promising 8.6% Upside

Exact Sciences Corporation (NASDAQ: EXAS) stands out in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $12.25 billion, this..

Abbott Laboratories (ABT): Investor Outlook with a 16.86% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare industry with a market capitalization of approximately $214.96 billion, continues to be a significant player in the..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotechnology Powerhouse with 149% Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands out as a formidable player within the biotechnology sector, emphasized by its impressive market capitalization of $60.25 billion. The company’s..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 23.28% Potential Upside with Healthcare Innovations

Solventum Corporation (NYSE: SOLV), a rising star in the healthcare sector, is capturing investor attention with its robust portfolio and diverse segment offerings. With a market..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Powerhouse with 39.64% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY), a leading player in the Health Information Services industry, is making waves in the market with its robust cloud-based software solutions..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 10% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the medical technology industry, presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds